Skip to search formSkip to main contentSkip to account menu

MM-093

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Gateways to clinical trials.
(-)-Epigallocatechin gallate, (-)-Gossypol; Ad.hIFN-beta, AF-37702, Agatolimod sodium, Agomelatine, Alvocidib hydrochloride, ARC… 
2007
2007
COX-2 inhibitor use in the Women's Health Initiative trials: re-analysis of the data
MM-093 significantly improved the mean disease activity score (DAS) 28 and the mean patient’s global assessment compared with… 
2007
2007
The use of antimalarial agents might confer an anti-cancer effect in patients with SLE
MM-093 significantly improved the mean disease activity score (DAS) 28 and the mean patient’s global assessment compared with… 
2007
2007
Gateways to clinical trials.
1-Octanol, 9vPnC-MnCc; Abiraterone acetate, Adalimumab, Adefovir dipivoxil, Alemtuzumab, Aliskiren fumarate, Aminolevulinic acid… 
2005
2005
A randomized double-blind, placebo-controlled trial of MM-093, a recombinant version of human alpha-fetoprotein, in patients with active rheumatoid arthritis (RA)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)